Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
NCT01758588Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2013
- Primary completion
- Jun 2017
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in primary myelofibrosis (PMF), sponsored by Weill Cornell Medicine. Started Jan 2013; status: terminated.
02
Drugs
peginterferon alfa-2b
03
Conditions
primary myelofibrosis (PMF)
Beyond the preview
Go deeper on NCT01758588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01758588.